Bloomberg -- AstraZeneca Plc is in “exploratory discussions” with competitors for partnerships that would help ease the cost and risk of developing new medicines, said Shaun Grady, vice president of corporate business development.
Bloomberg -- AstraZeneca Plc is in “exploratory discussions” with competitors for partnerships that would help ease the cost and risk of developing new medicines, said Shaun Grady, vice president of corporate business development.
